This job posting may have expired!
Use our `search` to find similar offers.
Similar jobs

Director Translational Biomarker Solutions

Laboratory Corporation of America Holdings (Covance)

SIMZ Pudong, Shanghai, China

1.      Director Translational Biomarker Solution should have a high level of expertise, management and experience, responsible for the management of Translational Biomarker Solution in China. To establish a sound organization to ensure that the personnel structure and qualification can meet the requirements of Biomarkers in clinical studies.   2.      Leadership on Translational Biomarker Solution a.   Build network for Exploratory Biomarker work in China. Develop internal process for biomarker solution.  Transfer fit for purpose assay development/validation from US to China. b.      Work with clients to provide expert advice on biomarker selection, characterization and development for their clinical trials in a timely fashion c.      Interact with LabCorp Drug Development technology groups to assure appropriate lead scientist are established to direct the assay development and implementation of the biomarkers in clinical research studies, including clinical trials, provide technical guidance for assay development and biomarker sample analysis. d.      Develops internal contacts to rapidly assess the incoming proposals and provide on time response to clients’ needs e.      Support CDx by working with the existing SMEs and Business Development staff. f.       Support integrated sales, and patient recruitment strategic initiatives g.      Supports the management of the budget and resourcing for the overall program   3.      Strategic Project Leadership for Biomarker work a. Contribute to the overall strategy and direction, including adapting and modifying objectives based on deep knowledge of the subject matter, feedback of team members and other stakeholders, and being focused entirely on this program. b. Proactively establish capabilities in areas of greatest needs c. Partner with LabCorp Drug Development business units, medical and scientific leaders to understand and communicate biomarker solutions. Provide scientific input into the development of a long-term product strategy roadmap, informed by client needs and competitive offerings. c. Provide scientific input into defining value propositions for multiple audiences, including: clients, investigators, and patients. d. Assess and monitor strategic position and marketplace presence of key competitors in biomarker across all Lapcorp Drug Development business areas. Provide scientific input to market strategy and competitive positioning as appropriate in partnership with business leadership to maintain competitive leadership and advantage. 1.      Advanced degree preferred (MD, PhD, MBA) but sufficient track record to ensure success will be considered       1.      Experienced in Translation Medicine. With a sound understanding of preclinical, clinical drug development and biomarker/companion assay development are preferred, as demonstrated by publication of manuscripts in scientifically relevant journals, books and/or presentation at international scientific meetings. 2.      Experienced in leading major projects to successful outcome 3.      Collaborative and team building skills critical 4.      Preferred 5-10 years’ experience in Pharma/CRO/and or diagnostic environment focused in Oncology<p></p><p><b>Labcorp is proud to be an Equal Opportunity Employer:</b></p><p></p><p>As an EOE/AA employer, the organization will not discriminate in its employment practices due to an applicant's race, age, color, religion, sex, national origin, sexual orientation, gender identity, disability or veteran status.</p><p></p><p>For <span>more information about how we collect and store your personal data, please see our </span><span><a href="https://www.labcorp.com/hipaa-privacy/web-privacy-policy" target="_blank">Privacy Statement</a></span><a href="https://www.labcorp.com/hipaa-privacy/web-privacy-policy" target="_blank"><span>.</span></a><span> </span></p>

Job posted: 2022-03-28

3